Prenetics Global: Is Undervalued, Supported By Portfolio Optimization In 2026 (Buy)
Source: SeekingAlpha
2026-01-17 00:58:28 ET
International health science company, Prenetics Global Limited ( PRE ), recently announced its decision to pause the purchase of Bitcoins and instead reallocate its capital towards the production and sale of its premium supplement, IM8. The stock is up 172% (YoY) and is trading just 17% below its 52-week high of $18.48. Still, I believe the stock is undervalued, and the management’s focus on raising revenue guidance through 2026 is a strategic move regarding its capital allocation....
Read the full article on Seeking Alpha
For further details see:
Prenetics Global: Is Undervalued, Supported By Portfolio Optimization In 2026 (Buy)
Prenetics Global Limited Warrant
NASDAQ: PRENW
PRENW Trading
1.08% G/L:
$0.0188 Last:
4,907 Volume:
$0.0186 Open:
PRENW Latest News
PRENW Stock Data
$275,277,671
10,562,738
N/A
8
N/A
Medical Diagnostics & Screening
Healthcare
HK
Hong Kong
